Y MAbs Correlations

YMAB Stock  USD 6.19  0.04  0.65%   
The current 90-days correlation between Y mAbs Therapeutics and Black Diamond Therapeutics is 0.32 (i.e., Weak diversification). The correlation of Y MAbs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Y MAbs Correlation With Market

Modest diversification

The correlation between Y mAbs Therapeutics and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Y mAbs Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Y mAbs Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Moving together with YMAB Stock

  0.76MBIO Mustang BioPairCorr
  0.76MBRX Moleculin BiotechPairCorr
  0.77MGNX MacroGenicsPairCorr
  0.84DNLI Denali TherapeuticsPairCorr
  0.79DNTH Dianthus TherapeuticsPairCorr
  0.84VERA Vera TherapeuticsPairCorr
  0.78DRUG Bright Minds BiosciencesPairCorr
  0.82MLYS Mineralys Therapeutics,PairCorr
  0.81DTIL Precision BioSciencesPairCorr
  0.86MNKD MannKind CorpPairCorr

Moving against YMAB Stock

  0.73DMAC DiaMedica TherapeuticsPairCorr
  0.68MESO MesoblastPairCorr
  0.68VCEL Vericel Corp OrdPairCorr
  0.53MDXG MiMedx GroupPairCorr
  0.48MDWD MediwoundPairCorr
  0.34MCRB Seres TherapeuticsPairCorr
  0.88DRTS Alpha Tau MedicalPairCorr
  0.77MNPR Monopar TherapeuticsPairCorr
  0.61VCYT VeracytePairCorr
  0.53MIST Milestone PharmaceuticalsPairCorr
  0.51SABSW SAB BiotherapeuticsPairCorr
  0.5CDIOW Cardio DiagnosticsPairCorr
  0.44MIRM Mirum PharmaceuticalsPairCorr
  0.44VCNX VaccinexPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ZNTLMRSN
GBIOBDTX
GBIORVMD
GBIOZNTL
MRSNRVMD
ZNTLRVMD
  
High negative correlations   
TVTXZNTL
TVTXMRSN
BLUERVMD
GBIOTVTX
TVTXRVMD
BLUEBDTX

Risk-Adjusted Indicators

There is a big difference between YMAB Stock performing well and Y MAbs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Y MAbs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TCRR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RVMD  1.83 (0.48) 0.00 (0.50) 0.00 
 2.27 
 15.16 
BDTX  3.46 (0.26) 0.00 (0.20) 0.00 
 5.02 
 25.91 
BCEL  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PASG  7.09  0.36  0.06  0.23  7.02 
 20.97 
 84.39 
BLUE  7.80  0.50  0.06  0.29  9.20 
 14.85 
 145.15 
MRSN  6.61 (1.51) 0.00 (0.38) 0.00 
 9.24 
 64.16 
ZNTL  4.57 (1.28) 0.00 (0.82) 0.00 
 8.00 
 32.39 
TVTX  2.46  0.29  0.08  3.23  2.27 
 5.93 
 20.58 
GBIO  3.73 (1.75) 0.00 (0.58) 0.00 
 6.29 
 22.69 

Y MAbs Corporate Management

MBBS MBASenior OfficerProfile
Sue SmithVP OfficerProfile
Doug GentilcoreSenior UnitProfile
FACNP FACPChief OfficerProfile
Courtney DuganVice RelationsProfile
Susan SmithSenior OfficerProfile